Table 2.
Comparison of biopsy specimens, safety, diagnosis, and prognosis between the patients underwent TBLB and TBLC
| TBLB (n = 45) | TBLC (n = 25) | p value | |
|---|---|---|---|
| Specimen (Median, IQR) | |||
| Number | 4 (2–6) | 4 (3–5) | 0.380 |
| Length diameter, mm | 1.0 (0.5–2.0) | 5.3 (4.8–5.6) | < 0.001 |
| Short diameter, mm | 0.5 (0.5–0.8) | 3.7 (3.3–4.3) | < 0.001 |
| Artifacts (n, %) | |||
| Crash/atelectasis | 25 (55.6) | 0 | < 0.001 |
| Traumatic bleeding | 4 (8.9) | 4 (16.0) | 0.443 |
| Non-alveolar tissue | 8 (17.8) | 0 | 0.044 |
| Complications (n, %) | 7 (15.6) | 7 (28.0) | 0.212 |
| Moderate bleeding | 0 | 7 (28.0) | < 0.001 |
| Severe bleeding | 0 | 0 | – |
| Pneumothorax | 6 (13.3) | 0 | 0.056 |
| Others | 1 (2.2) | 0 | 1.000 |
| ΔAPACHE II score ≥ 5 (n, %) | 0 | 4 (16.0) | 0.006 |
| ΔSOFA score ≥ 3 (n, %) | 1 (2.2) | 4 (16.0) | 0.032 |
| Pathological diagnosis (n, %) | 17 (37.8) | 18 (72.0) | 0.006 |
| MDD diagnosis (n, %) | 25 (55.6) | 21 (84.0) | 0.016 |
| Treatment modifications (n, %) | 26 (57.8) | 21 (84.0) | 0.025 |
| 28-day survival (n, %) | 25 (55.6) | 16 (64.0) | 0.492 |
APACHE II score, acute physiology and chronic health evaluation II score; SOFA score, sequential organ failure assessment score; MDD, Multidisciplinary discussion
Bold for statistically significant (p value < 0.05)